Quantcast

Latest Biguanides Stories

2014-06-17 08:28:54

- Recent Publication Shows Metformin Improves Glycemic Control by Modulating the Gut Microbiome and Triggering Specific Cellular and Immune Mechanisms - BROOMFIELD, Colo., June 17, 2014 /PRNewswire/ -- MicroBiome Therapeutics(TM) LLC, (MBT) today reported that a recently published scientific study shows that the diabetes drug, metformin, alters the bacterial populations in the gut in favor of a bacterial species that exerts specific cellular and immunological effects, resulting...

2014-06-10 20:23:10

ROCKVILLE, Md., June 10, 2014 /PRNewswire-USNewswire/ -- Patients with type 2 diabetes who take a combination of metformin plus insulin may be at higher risk for cardiovascular disease and death compared with those who take a combination of metformin plus sulfonylurea, according to a new study funded by the Agency for Healthcare Research and Quality (AHRQ) that appears in the June 11 issue of JAMA. The study, a review of medical records from national databases, found a greater...

2014-03-26 08:28:48

DUBLIN, Mar. 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5bf97k/research_report ) has announced the addition of the "Concise Analysis of the Chinese Antidiabetic Drug Market" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) As China's society is further aging and obesity caused by improved living level and unhealthy lifestyle is increasing, the prevention and cure to diabetes become more difficult. The...

2014-01-13 16:25:24

CINCINNATI, Jan. 13, 2014 /PRNewswire-USNewswire/ -- The diabetes drug metformin is also being tested in numerous clinical trials for treating different cancers, and several studies point to its apparent activation of a molecular regulator of cell metabolism called AMPK to suppress tumor growth. (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) But new research appearing the week of Jan. 13 in Proceedings of the National Academy of Sciences (PNAS) suggests that...

diabetes med affects men's and women's hearts differently
2013-12-12 15:24:01

Brett Smith for redOrbit.com - Your Universe Online In a new study from researchers at at Washington University School of Medicine, the type 2 diabetes drug metformin was found to have different effects on the hearts of men and women, despite managing blood sugar the same in both sexes. According to the study, which was published in the December issue of the American Journal of Physiology - Heart and Circulatory Physiology, the drug had positive effects on women’s heart health, but...

2013-11-20 23:01:29

A new study published online in The Oncologist journal shows that cancer patients with concurrent type 2 diabetes treated with metformin have a greater overall survival rate compared with patients taking other glucose-lowering medications. A team of researchers led by Ming Yin, MD, at Geisinger Medical Center in Danville, PA, performed a meta-analysis to evaluate the association of metformin treatment and both overall and cancer-specific survival. Durham, NC (PRWEB) November 20, 2013 Over...

2013-11-04 14:18:31

Metformin may reduce food intake and body weight, but the anorexigenic effects of metformin are still poorly understood. Under normal physiological conditions, Prof. Zheng Zhao and his team from the Key Laboratory of Brain Functional Genomics, Ministry of Education, China observed the changes in food intake after administration of metformin. They found that the central administration of metformin significantly reduced food intake and body weight gain, and a reduction of neuropeptide Y...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related